New Study Confirms Bioengineered RSV Protein Vaccine Evokes Protective Immune Response
Published:15 Mar.2022 Source:University of California - Santa Cruz
Close interactions with infectious disease set both University of California, Santa Cruz graduate student Ana Nuñez Castrejon and Associate Professor of Biomolecular Engineering Rebecca DuBois on the path of studying Respiratory syncytial virus (RSV), a common and sometimes dangerous respiratory disease for which there is not currently a vaccine.
The two researchers recently marked a major milestone in their effort to create an effective vaccine for the virus with the publishing of their paper "Structure-based design and antigenic validation of respiratory syncytial virus G immunogens" in the Journal of Virology.